INSUBCONTINENT EXCLUSIVE:
Sagar Doshi of Edelweiss Financial Services has a buy call on Sun Pharmaceutical Industries Ltd
with a target price of Rs 470.0
The current price of Sun Pharmaceutical Industries Ltd
Sagar Doshi recommended to keep a stoploss at Rs 430
Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 107094.32 Crore)
operating in Pharmaceuticals sector
Sun Pharmaceutical Industries Ltd
key Products/Revenue Segments include Pharmaceuticals which contributed Rs 9783.29 Crore to Sales Value (94.95 % of Total Sales),
Pharmaceuticals which contributed Rs 9783.29 Crore to Sales Value (94.95 % of Total Sales), Pharmaceuticals which contributed Rs 9783.29
Crore to Sales Value (94.95 % of Total Sales), Other Operating Revenue which contributed Rs 519.92 Crore to Sales Value (5.04 % of Total
Sales), Other Operating Revenue which contributed Rs 519.92 Crore to Sales Value (5.04 % of Total Sales) and Other Operating Revenue which
contributed Rs 519.92 Crore to Sales Value (5.04 % of Total Sales)for the year ending 31-Mar-2019
For the quarter ended 30-09-2019, the company has reported a Consolidated sales of Rs 7949.19 Crore, down -3.75 % from last quarter Sales
of Rs 8259.30 Crore and up 16.11 % from last year same quarter Sales of Rs 6846.48 Crore Company has reported net profit after tax of Rs
1167.35 Crore in latest quarter
The company’s top management includes Mr.Ashwin Dani, Mr.Sudhir V Valia, Mr.Sailesh T Desai, Mr.S Mohanchand Dadha, Mr.Keki M Mistry,
Mr.Kalyanasundaram Subramanian, Mr.Israel Makov, Mr.Hasmukh S Shah, Mr.Dilip S Shanghvi, Ms.Rekha Sethi
LLP as its auditoRs As on 30-09-2019, the company has a total of 2,399,334,970 shares outstanding.